RGCB Team Develops Nanopore Sensors to Detect Parkinson’s Biomarkers
Researchers at Kerala’s Rajiv Gandhi Centre for Biotechnology have developed nanopore sensors designed to detect biomarkers associated with Parkinson’s disease and other neurodegenerative conditions. The team described the devices as self-assembling and dual-diameter, with high sensitivity.
Researchers at the Rajiv Gandhi Centre for Biotechnology in Kerala have developed nanopore sensors for the early detection of Parkinson’s disease, The Hindu reported. The RGCB team designed what it described as self-assembling, dual-diameter nanopore sensors. The devices are capable of detecting biomarkers linked to neurodegenerative diseases with high sensitivity, according to the supplied material.
The reported work focuses on identifying biological markers associated with Parkinson’s disease. The material does not specify which biomarkers were tested or describe how the sensors performed in clinical settings. It also does not provide details about the technology’s development stage, possible medical use or timeline for wider application.
The available information identifies the research team and the sensors’ reported detection capability but gives no further results.
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.